"The administration of President Donald Trump has proposed a suite of new rules that seek to bar hospitals across the United States from performing gender-affirming healthcare for transgender youth below 18 years of age. On Thursday, the Centers for Medicare and Medicaid Services (CMS) announced that one of the proposed rules would block hospitals and clinics from accessing its programmes if they chose to continue providing gender-affirming care."
"Both Medicare and Medicaid are forms of government-provided health insurance, offered to vulnerable groups. Medicaid primarily serves low-income households, while Medicare offers coverage to older Americans and people with disabilities. In a statement, the Trump administration noted that the vast majority of healthcare providers work with Medicare and Medicaid to provide health coverage for their patients. The proposed rule would therefore amount to a de facto ban on gender-affirming care."
"In addition to the two proposed rules, Health and Human Services Secretary Robert F Kennedy Jr signed a declaration on Thursday rejecting gender-affirming care as detrimental to youth. Under his orders, the Food and Drug Administration also issued notices to 12 manufacturers of chest binders which flatten the upper torso, where breasts are warning that marketing to transgender youth would be considered illegal under the current administration."
Critics warn that the administration's statements against transgender healthcare contradict decades of research. The administration proposed rules to bar hospitals from performing gender-affirming care for transgender youth under 18. CMS announced a proposed rule that would block hospitals and clinics from accessing its programmes if they continued providing gender-affirming care. A second rule would prohibit federal Medicaid funds from covering gender-affirming procedures. Medicare and Medicaid serve vulnerable groups, and nearly all US hospitals participate in those programmes, so the rules would function as a de facto ban. HHS leadership rejected gender-affirming care and the FDA warned chest-binder manufacturers about marketing to transgender youth.
Read at www.aljazeera.com
Unable to calculate read time
Collection
[
|
...
]